Effect of a Web-based Application With Integrated AI Chat for Cardiovascular Risk Support
NCT07917000, Not applicable, Not yet recruiting, Cairo University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Effect of a Web-based Application With Integrated AI Chat for Cardiovascular Risk Support | ClinicalTrials.gov |
| NCT number | NCT07917000 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 116 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Cairo University | ClinicalTrials.gov |
| Conditions | AI Chatbot, Cardiovascular (CV) Risk | ClinicalTrials.gov |
| Interventions | web application with AI chat, usual clinic care follows the national prevention and management guidelines for major cardiovascular risk factors | ClinicalTrials.gov |
| First posted | 2026-11-04 | ClinicalTrials.gov |
| Last updated | 2026-11-04 | ClinicalTrials.gov |
Registered outcomes 9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Mean absolute change in predicted 10-year cardiovascular risk (%) from baseline to 3 months in intervention and control groups. | 3 months | ClinicalTrials.gov | |
| Secondary | Mean change in systolic BP (mmHg) | 3 months | Change in systolic blood pressure from baseline to 3 months, measured in mmHg. | ClinicalTrials.gov |
| Secondary | Mean change in diastolic blood pressure | 3 months | Change in diastolic blood pressure from baseline to 3 months, measured in mmHg. | ClinicalTrials.gov |
| Secondary | Mean change in LDL cholesterol | 3 months | Change in low-density lipoprotein (LDL) cholesterol level from baseline to 3 months, measured in mg/dL. | ClinicalTrials.gov |
| Secondary | Mean change in HDL cholesterol | 3 months | Change in high-density lipoprotein (HDL) cholesterol level from baseline to 3 months, measured in mg/dL. | ClinicalTrials.gov |
| Secondary | Mean change in total cholesterol | 3 months | Change in total cholesterol level from baseline to 3 months, measured in mg/dL. | ClinicalTrials.gov |
| Secondary | Mean change in HbA1c among participants with diabetes | 3 months | Change in glycated hemoglobin (HbA1c) from baseline to 3 months among participants with diabetes, measured as a percentage (%). | ClinicalTrials.gov |
| Secondary | System Usability Scale (SUS) score | 3 months | Usability of the web-based application will be assessed using the 10-item System Usability Scale (SUS), with total scores ranging from 0 to 100. Higher scores indicate better perceived usability. | ClinicalTrials.gov |
| Secondary | Change in medication adherence score | 3 months | Change in medication adherence from baseline to 3 months, assessed using Adherence to Refills and Medications Scale (ARMS) questionnaire . It consists of 12 items covering two main domains: medication-taking behavior and prescription refill adherence Each item is scored on a 4-point Likert scale ranging from 1 (none of the time) to 4 (all of the time), with higher scores indicating lower adherence | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)